OLP is the mucosal counterpart of cutaneous LP which is a chronic mucocutaneous disorder of stratified squamous epithelium that affects oral and genital mucous membranes, skin, nails, and scalp. Epidermal Growth Factor (EGF) is the prototypical member of a family of peptide growth factors that activate the EGFR, Despite the strong association of EGFR over expression with oral carcinogenesis, although few studies have analyzed its expression in OLP. The aim of this work is to measure serum and tissue levels of EGF in patients with oral lichen planus in comparison to normal controls, in order to investigate the role of EGF in the pathogenesis of oral lichen planus.
INTRODUCTION
Lichen planus (LP) is an inflammatory mucocutaneous condition with characteristic clinical and histopathological findings. It is a disorder of the stratified squamous epithelium affecting skin, oral and genital mucous membranes, nails, and scalp [1] . In the oral cavity, the disease is somewhat different in clinical appearance than on the skin [2] .
OLP is one of the most common oral mucosal lesions affecting 0.5% to 2% of the adult population. It mainly affects middle-aged and elderly, and is more prevalent in women than in men [3] .
Epidermal growth factor (EGF) is a member of a family of peptide growth factors that activate the EGF receptors, and that the EGF/EGFR signalling pathway plays important roles in proliferation, differentiation and migration of a variety of cell types, especially in epithelial cells. Recently studies denote that EGF and its signalling pathway have extended to a broad range of biological and pathophysiological roles in development and in human diseases [4] .
Despite the strong association of EGFR overexpression with oral carcinogenesis of oral potentially malignant lesions (OPML), few studies have analysed its expression in OLP, showing controversial results [5] . 
PATIENTS AND METHODS

DISCUSSION
Epidermal growth factor is the prototypical member of a family of peptide growth factors that activate the EGF receptors, and that the EGF/EGF receptor signaling pathway plays important role in proliferation, differentiation and migration of a variety of cell types, especially in epithelial cells. After that, the studies related to EGF and its signaling pathway have extended to a broad range of investigations concerning its biological and pathophysiological roles in development and in human diseases [4] .
In this study, according to statistical results of serum and tissue levels of EGF in OLP and control groups, the levels were significantly lower in OLP group compared to healthy control group (p <0.05). overexpressed in a great percentage of OLD cases [6] .
Agha-Hosseini et al.(2015)
, as well as this study have observed that the mean serum EGF in OLP and OSCC patients was significantly lower compared to healthy control group (p<0.05), but no significant difference was observed between OLP and OSCC patients.
There was no significant difference in mean salivary EGF among groups. As serum EGF levels appear to be statistically similar in OLP and OSCC, it seems that EGF might play a role in the pathogenesis of OLP and its cancerization [7] .
CONCLUSION
In conclusion, the mean serum and tissue level of EGF in OLP patients was significantly lower compared to healthy control . There is a strong correlation between EGF and OLP, but the previous studies done are not sufficient enough to explain this relation.
